What Qure.ai Announced About the Aira CE Certification
Qure.ai said on 17 September 2026 that its clinical decision support system Aira received Class IIb CE certification under the European Union Medical Device Regulation, and the company describes it as among the first in the world to hold that certification for this kind of product. The announcement does not mention any FDA status for Aira.
Why the Qure.ai Aira Class IIb Certification Matters to European Buyers
A Class IIb certification in Europe is a real step up from the risk class that covers triage software, and it tells a European health service that the product was reviewed for a decision support role. It says nothing about the United States, where Aira is not described as cleared, so an American buyer should not read this as an FDA decision. Qure.ai's chest X-ray products and Aira are governed by separate approvals, and the paperwork does not transfer between them.
Where the Qure.ai Update Comes From
Qure.ai is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.
How We Would Research the Qure.ai Aira Certification
The source gives us the starting point. This is how we would build the next layer of research around it.
- We would start with the certificate itself and read which intended use the notified body accepted for Aira.
- Then we would ask Qure.ai, in writing, what regulatory status Aira holds in the United States, because the announcement is silent on it.
- We would separate Aira's certification from the company's chest X-ray clearances when comparing vendors, since a buyer only gets the approval that covers the product being bought.